CD200 and acute myeloid leukemia: Coles et al. observed a reduction of activated natural killer cells, defective NK cytolytic activity, reduced CD4 Th1 memory and memory cytotoxic response, and high Treg frequency in cases of AML with CD200 expression, thus explaining the increased relapse risk and the worse survival among these patients [32,33,34].